Quarterly report pursuant to Section 13 or 15(d)

5. STOCKHOLDERS' EQUITY (DEFICIT) (Details 2)

v3.7.0.1
5. STOCKHOLDERS' EQUITY (DEFICIT) (Details 2) - USD ($)
 3 Months Ended 6 Months Ended
Jun. 30, 2017
Jun. 30, 2016
Jun. 30, 2017
Jun. 30, 2016
Total stock-based compensation expense $ 311,363 $ 310,945 $ 547,240 $ 733,125
Research and development        
Total stock-based compensation expense 68,434 132,277 121,417 288,833
Plasma centers        
Total stock-based compensation expense 13,196 11,745 25,947 24,755
General and administrative        
Total stock-based compensation expense 223,973 166,923 394,116 419,537
Cost of goods sold        
Total stock-based compensation expense $ 5,760 $ 0 $ 5,760 $ 0